Myelodysplastic syndrome Initial PBS authority application and supporting information form (PB012)

Lodge this form for a patient starting initial PBS subsidised treatment with lenalidomide or applying for the first continuing PBS subsidised treatment. The patient and prescriber acknowledgements must be completed.


Page last updated: 5 February 2016

This information was printed Thursday 29 September 2016 from It may not include all of the relevant information on this topic. Please consider any relevant site notices at when using this material.